LDL cholesterol is the cholesterol carried out to your tissues, and when there's more than the body needs it can slowly build up in artery walls. That build-up happens over decades, so LDL is worth knowing well before anything feels wrong. Genes, diet, weight and thyroid function all play a part. The lab range is 1.7 to 3.5 mmol/L, and we aim for 1.7 to 2.5 mmol/L. LDL is part of the Vively Baseline Health Check, and you'll see it in the app next to your HDL and triglycerides, so you can watch how it trends from one test to the next.
Check LDL Cholesterol alongside 70+ other markers in Vively's Baseline Health Check.
Every marker in range? Get your money back. T&Cs apply.LDL, or low-density lipoprotein, is one of the particles your body uses to carry cholesterol through the bloodstream. It is often called "bad" cholesterol, though that description is a simplification. LDL particles deliver cholesterol from the liver to the rest of the body, and when there are too many of them, cholesterol can accumulate in artery walls and contribute to plaque formation. LDL cholesterol (LDL-C) measures the amount of cholesterol carried inside LDL particles, and in Australia it is reported in mmol/L.
LDL is a standard part of a lipid panel and one of the most widely used markers for estimating cardiovascular risk. It is often more useful when read alongside HDL, non-HDL, triglycerides and, where available, ApoB, which counts the actual number of atherogenic particles. You can read more about the bigger picture in our article on advanced lipid testing beyond LDL cholesterol.
Elevated LDL cholesterol is one of the most well-established causes of atherosclerotic cardiovascular disease, the underlying condition behind most heart attacks and strokes. The relationship is dose-dependent, meaning the higher the LDL and the longer it has been elevated, the greater the cumulative damage to artery walls over time. Cardiovascular disease remains the leading cause of death in Australia, so understanding this marker matters.
LDL also connects to broader health. High LDL often clusters with insulin resistance, high triglycerides, low HDL, fatty liver disease and metabolic syndrome, all of which influence energy, weight and long-term ageing. Because much of the damage from elevated LDL is silent for decades, checking it early gives you a chance to act before symptoms appear. It is one of the core lipid markers Vively tracks as part of its baseline health testing.
In Australia, LDL cholesterol targets depend on your absolute cardiovascular risk rather than being a single "normal" number. For adults at low overall risk, LDL below around 2.5 to 3.5 mmol/L is generally acceptable. For people at high absolute cardiovascular risk, guidelines aim for LDL below 2.0 mmol/L, and for those with established cardiovascular disease or very high risk (such as familial hypercholesterolaemia), targets of 1.8 mmol/L or lower are often recommended.
There is no universal ideal number. Interpretation depends on your age, sex, family history, blood pressure, smoking status, diabetes, kidney function, other lipid markers and overall cardiovascular risk score. Your GP or cardiologist can calculate your absolute risk and set a target that reflects your personal situation.
Diet has a strong influence. Saturated fat, trans fat, dietary cholesterol and refined carbohydrates tend to raise LDL, while soluble fibre, plant sterols, unsaturated fats (from olive oil, nuts, avocados and oily fish) and legumes tend to lower it. Body composition also matters, particularly visceral fat, along with physical activity levels, smoking status, alcohol intake and sleep quality.
Genetics play a significant role. Familial hypercholesterolaemia is a common inherited condition that causes very high LDL from birth and dramatically increases early cardiovascular risk. Other influences include thyroid function (an underactive thyroid can raise LDL), liver and kidney disease, pregnancy, menopause and medications such as corticosteroids, some diuretics and certain immunosuppressants. Statins, ezetimibe and other lipid-lowering therapies can substantially reduce LDL.
High LDL cholesterol usually has no symptoms. It is often only discovered through blood testing, or unfortunately, after a cardiovascular event such as a heart attack or stroke. Very rare exceptions include physical signs of familial hypercholesterolaemia, such as fatty deposits on tendons (tendon xanthomas), yellowish patches around the eyes (xanthelasma) or a whitish ring around the cornea in younger adults (corneal arcus).
Because elevated LDL is silent for so long, waiting for symptoms is not a safe strategy. Testing is the only reliable way to know your levels, especially if you have a family history of early heart disease, high cholesterol or stroke.
Common contributors include a diet high in saturated fat, trans fat and refined carbohydrates, low intake of fibre and unsaturated fats, sedentary lifestyle, excess visceral fat, smoking and heavy alcohol use. Genetic factors are also significant, especially familial hypercholesterolaemia, which is more common than many people realise.
Medical conditions can raise LDL too, including hypothyroidism, nephrotic syndrome, chronic kidney disease, cholestatic liver disease and poorly controlled diabetes. Certain medications, including corticosteroids, some diuretics, cyclosporin and some antipsychotics, can also lift LDL. Hormonal changes, particularly menopause, often shift lipids in a less favourable direction, which is one reason lipids are worth rechecking during and after this life stage.
In most people, a low LDL cholesterol is protective and generally desirable, especially for cardiovascular health. Decades of research consistently show that lower LDL is associated with lower risk of heart attack and stroke, whether achieved through lifestyle, statins or genetics.
Very low LDL is only rarely a concern, and usually only when caused by an underlying condition such as significant malnutrition, malabsorption, hyperthyroidism, chronic liver disease, some rare genetic conditions or serious systemic illness. In these situations, other markers will typically be abnormal too. If your LDL is unexpectedly low without a clear reason, your GP will look at the wider picture rather than the LDL number in isolation.
A higher-than-target LDL suggests that too many cholesterol-carrying particles are circulating, which over time contributes to plaque build-up in arteries. It does not diagnose cardiovascular disease, but it is a strong risk factor, particularly when combined with high blood pressure, smoking, diabetes, insulin resistance, family history or elevated ApoB or Lp(a). The higher your LDL and the longer it stays elevated, the more cumulative exposure your arteries have.
A very low LDL is generally protective, but if it appears unexpectedly, it may point to an underlying condition rather than good health. As with all lipid markers, patterns over time and the context of your other results matter more than any single reading.
Yes. A "normal" LDL cholesterol does not always rule out cardiovascular risk. LDL-C measures the amount of cholesterol inside LDL particles, but two people with the same LDL-C can have very different particle numbers. If you have many small, dense LDL particles (a pattern often seen in insulin resistance, metabolic syndrome and high triglycerides), your ApoB may be elevated even when LDL-C looks acceptable. ApoB counts the actual number of atherogenic particles and is increasingly considered a more precise risk marker.
Standard LDL calculations can also be less accurate when triglycerides are high. Inflammation, elevated Lp(a) (a genetically driven risk factor), high blood pressure, insulin resistance and family history can all contribute to risk independently of LDL. Our ApoB blood test guide explains how these markers work together to give a fuller picture.
LDL is most useful when interpreted as part of a full lipid profile. HDL cholesterol shows how much cholesterol is being cleared from tissues, non-HDL cholesterol (total cholesterol minus HDL) captures all atherogenic cholesterol in one number, and triglycerides add insight into metabolic health. The total cholesterol to HDL ratio is another simple but useful summary of cardiovascular risk, as explained in our guide to understanding the total cholesterol to HDL ratio.
Advanced markers add further depth. ApoB counts the number of atherogenic particles, and Lp(a) reflects a largely genetic contribution to risk that standard cholesterol tests miss. hs-CRP measures low-grade inflammation, HbA1c and fasting insulin capture metabolic health, and liver enzymes such as ALT can flag fatty liver disease. Blood pressure, waist circumference, smoking status and family history are also essential context. You can see the full set of markers Vively looks at through our tests page and shop tests page.
Lifestyle changes can meaningfully shift LDL for many people. Diet is one of the biggest levers: reducing saturated fat (fatty cuts of meat, processed meats, butter, cream, coconut oil, palm oil, deep-fried and ultra-processed foods) and increasing soluble fibre (oats, legumes, psyllium, fruit and vegetables) along with unsaturated fats from olive oil, nuts, seeds, avocados and oily fish tends to lower LDL. Plant sterols and stanols, found in some fortified foods, can add a further modest reduction.
Regular movement, healthy body composition, quitting smoking, moderating alcohol and prioritising sleep all support healthier lipids. For people with high absolute cardiovascular risk, familial hypercholesterolaemia or established cardiovascular disease, lifestyle changes alone are often not enough, and medications such as statins or ezetimibe may be recommended. Not every marker can or should be self-optimised. Vively's how it works page explains how testing, monitoring and dietitian coaching combine to make change practical.
See your GP if your LDL is persistently elevated, is rising over time, or is very high (particularly above 5.0 mmol/L, which may suggest familial hypercholesterolaemia). Clinical review is also important if you have a family history of premature heart attack or stroke, established cardiovascular disease, diabetes, chronic kidney disease, high blood pressure, hypothyroidism or PCOS.
Pregnancy and planning pregnancy can affect lipid decisions, since some cholesterol-lowering medications are not safe in pregnancy. Menopause commonly changes lipids and is often a good time to reassess. Any chest pain, breathlessness, palpitations or other cardiovascular symptoms should be discussed with your GP promptly, regardless of your LDL level. LDL should never be self-diagnosed, as it is one piece of a bigger clinical picture your GP or cardiologist can help you interpret through an absolute cardiovascular risk assessment.
LDL cholesterol is one of the lipid markers included in the Vively Baseline Health Check, alongside HDL, non-HDL, triglycerides, cholesterol ratios, ApoB, Lp(a) and more than 60 other biomarkers spanning metabolic, liver, kidney, inflammation and hormonal health. Rather than looking at LDL in isolation, Vively interprets it in context with your other results, symptoms, lifestyle and family history.
An accredited practising dietitian reviews your results with you one on one, helping you understand what they mean and what changes may support your health goals. Because your markers are retested over time, you can see how nutrition, movement, sleep and other habits are shifting your lipid profile rather than guessing. Start at the Vively homepage or explore the full range of tests in the Vively shop.
Among 5,968 Vively members tested in 2024 to 2026, women aged 40 to 49 had a median LDL cholesterol of 2.9 mmol/L (middle half 2.4 to 3.4). Men the same age: 3.2 mmol/L. The lab range is 1.7 to 3.5 mmol/L. A member median is not a target.
The line is the median member at each age. The shaded bands show where most members sit. The dashed red lines are the lab range.
| Group (mmol/L) | Members | Median | Middle 50% | 5th to 95th percentile | Lab range |
|---|---|---|---|---|---|
| Women 18 to 29 | 260 | 2.5 | 2.1 to 3.0 | 1.4 to 3.8 | 1.7 to 3.5 |
| Women 30 to 39 | 973 | 2.6 | 2.2 to 3.2 | 1.7 to 4.1 | 1.7 to 3.5 |
| Women 40 to 49 | 1,142 | 2.9 | 2.4 to 3.4 | 1.8 to 4.4 | 1.7 to 3.5 |
| Women 50 to 59 | 855 | 3.2 | 2.6 to 3.8 | 1.9 to 5.0 | 1.7 to 3.5 |
| Women 60 and over | 488 | 3.3 | 2.8 to 4.1 | 1.7 to 5.3 | 1.7 to 3.5 |
| Men 18 to 29 | 262 | 2.7 | 2.3 to 3.3 | 1.8 to 4.2 | 1.7 to 3.5 |
| Men 30 to 39 | 641 | 3.0 | 2.5 to 3.6 | 1.9 to 4.7 | 1.7 to 3.5 |
| Men 40 to 49 | 684 | 3.2 | 2.6 to 3.9 | 1.8 to 4.9 | 1.7 to 3.5 |
| Men 50 to 59 | 406 | 3.2 | 2.6 to 4.0 | 1.6 to 5.3 | 1.7 to 3.5 |
| Men 60 and over | 257 | 3.2 | 2.4 to 3.9 | 1.5 to 5.1 | 1.7 to 3.5 |
Pick your sex and age, then type your result.
What is a normal LDL cholesterol level for my age?
Among 5,968 Vively members (first blood test, January 2024 to October 2026), the median LDL cholesterol for women was 2.5 mmol/L at 18 to 29, 2.6 at 30 to 39, 2.9 at 40 to 49, 3.2 at 50 to 59 and 3.3 at 60 and over. For men it was 2.7 mmol/L at 18 to 29, 3.0 at 30 to 39, 3.2 at 40 to 49, 3.2 at 50 to 59 and 3.2 at 60 and over.
The lab range is 1.7 to 3.5 mmol/L. A member median is not a target or a diagnosis. If your result is outside the range on your report, talk to your GP.
How to get it: Included in the Baseline Health Check. A GP from our network signs your request after a short telehealth consult, so you don't need to visit your own GP first. See how a blood test without a referral works.
Related tests: LDL Cholesterol / Total Cholesterol (Mass Ratio), LDL/HDL Ratio, LDL-C / ApoB, hs-CRP / HDL Ratio
Learn more: Beyond LDL cholesterol: why ApoB and lipoprotein(a) could save your life; Top 5 longevity biomarkers: tests to extend your healthspan
Guide: LDL and total cholesterol by age, with Vively member data.
The Baseline Health Check reads 70+ markers, then your dietitian turns your results into a plan. $99$79 this Black Friday, ends 1 Dec. Then $99 a month, cancel anytime.
Every marker in range? Get your money back. T&Cs apply.